View the shortlist for Best New Life Sciences Product of 2019
Join SelectScience on Tuesday, May 12, at the Virtual Summit on Cancer and Immunology Research to find out the winner
Join SelectScience on Tuesday, May 12, at the Virtual Summit on Cancer and Immunology Research to find out the winner
Join this expert webinar for a review of the power of microfluidics for dynamic time-lapse experiments
Clinical laboratories certified to perform high complexity tests under Clinical Laboratory Improvement Amendments (CLIA) can immediately begin using this ELISA
Register today to reserve a place at the Summit - it opens at 13:00 (BST) / 14:00 (CEST) / 08:00 (EDT) / 05:00 (PDT) on Monday, May 11
AMSBIO's new service utilizes their novel lentiviral system to aid the development of therapeutic drugs and vaccines
Up to five different fluorescence channels are designed to allow researchers to explore new applications, such as metabolism, with addition of new live-cell ATP and MMP assays
Preliminary results from a government-sponsored study suggest that drug used to treat Ebola may help COVID-19 patients
The blood-based immunoassay test enables clinicians to identify the virus linked with COVID-19
Introducing Univercells Technologies, Univercells’ subsidiary focused on the development and commercialization of intensified, automated biomanufacturing technologies
Automated workflow optimized to extract pure DNA/RNA from the novel coronavirus, SARS-CoV-2
Bio-Rad Laboratories has launched a range of anti-certolizumab pegol inhibitory antibodies to support the development of anti-drug antibody (ADA) assays
Designed with a porous glass membrane for transmigration and transport studies under both static and flow conditions
Discover the latest research applications using multiplex technology to maximize sample use, while saving time and money
From flow cytometry and kinetic analysis to porous membranes and liquid handling, find out the latest techniques and technologies advancing cell-based assays
Watch our on-demand webinar to learn how to expand your lab capabilities with this mass spectroscopy technology
The serology test promises 100% sensitivity and can help assess patients' immune response to the virus
Join this upcoming webinar to understand how NMR-based metabolomics can provide important information at all stages of the cancer timeline
The molecular test kit promises 100% diagnostic sensitivity and specificity, and is authorized for clinical practice use in Europe
The antibody test, which has a potential time to result of 14 minutes, will join the rest of the company's diagnostic portfolio
Download this white paper from Sartorius to find out how advanced flow cytometry addresses the challenges and demands of modern drug discovery pipelines
OncoSpan range expanded to include FFPE and cfDNA formats to mimic solid tumors and liquid biopsy samples, respectively
The company aims to provide solutions for the pandemic through close collaboration with scientists and providing cutting-edge laboratory equipment
Learn more about how BINDER is helping countless laboratories across the world conduct research into coronavirus.